These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 9755438)
1. Effect of time on liver clearance of technetium-99m-tetrofosmin in patients with acute chest pain: when should imaging begin? Mann A; Ahlberg AW; White MP; Cross DM; Piriz J; Morris RS; Heller GV J Nucl Med Technol; 1998 Sep; 26(3):186-90. PubMed ID: 9755438 [TBL] [Abstract][Full Text] [Related]
2. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease. Münch G; Neverve J; Matsunari I; Schröter G; Schwaiger M J Nucl Med; 1997 Mar; 38(3):428-32. PubMed ID: 9074532 [TBL] [Abstract][Full Text] [Related]
3. Comparative myocardial uptake of technetium-99 m sestamibi and technetium-99m tetrofosmin one hour after stress injection. Gremillet E; Champailler A Eur J Nucl Med; 1998 Nov; 25(11):1502-10. PubMed ID: 9799346 [TBL] [Abstract][Full Text] [Related]
4. 99mTc-N-DBODC5, a new myocardial perfusion imaging agent with rapid liver clearance: comparison with 99mTc-sestamibi and 99mTc-tetrofosmin in rats. Hatada K; Riou LM; Ruiz M; Yamamichi Y; Duatti A; Lima RL; Goode AR; Watson DD; Beller GA; Glover DK J Nucl Med; 2004 Dec; 45(12):2095-101. PubMed ID: 15585487 [TBL] [Abstract][Full Text] [Related]
5. Efficiency comparison between 99m Tc-tetrofosmin and 99m Tc-sestamibi myocardial perfusion studies. Ravizzini GC; Hanson MW; Shaw LK; Wong TZ; Hagge RJ; Pagnanelli RA; Jain D; Lima HS; Coleman RE; Borges-Neto S Nucl Med Commun; 2002 Mar; 23(3):203-8. PubMed ID: 11891477 [TBL] [Abstract][Full Text] [Related]
6. Myocardial tomography with technetium-99m-tetrofosmin during intravenous infusion of adenosine triphosphate. Takeishi Y; Takahashi N; Fujiwara S; Atsumi H; Takahashi K; Tomoike H J Nucl Med; 1998 Apr; 39(4):582-6. PubMed ID: 9544660 [TBL] [Abstract][Full Text] [Related]
10. Technetium-99m-tetrofosmin to assess myocardial blood flow: experimental validation in an intact canine model of ischemia. Sinusas AJ; Shi Q; Saltzberg MT; Vitols P; Jain D; Wackers FJ; Zaret BL J Nucl Med; 1994 Apr; 35(4):664-71. PubMed ID: 8151391 [TBL] [Abstract][Full Text] [Related]
11. Influence of the different biokinetics of sestamibi and tetrofosmin on the interpretation of myocardial perfusion imaging in daily practice. Hambÿe AS; Delsarte P; Vervaet AM Nucl Med Commun; 2007 May; 28(5):383-90. PubMed ID: 17414888 [TBL] [Abstract][Full Text] [Related]
12. [Improved detection of fill-in using sublingual nitroglycerin in technetium-99m tetrofosmin exercise/rest single photon emission computed tomography one day protocol for old myocardial infarction]. Miyanaga H; Kunieda Y; Oguni A; Kamitani T; Kawasaki S; Takahashi T J Cardiol; 1999 Mar; 33(3):135-43. PubMed ID: 10225193 [TBL] [Abstract][Full Text] [Related]
13. Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocol. Jain D; Wackers FJ; Mattera J; McMahon M; Sinusas AJ; Zaret BL J Nucl Med; 1993 Aug; 34(8):1254-9. PubMed ID: 8326381 [TBL] [Abstract][Full Text] [Related]
14. Comparison of cardiac to hepatic uptake of 99mTc-tetrofosmin with and without adenosine infusion to predict the presence of haemodynamically significant coronary artery disease. Squires SR; Bushnell DL; Menda Y; Graham MM Nucl Med Commun; 2005 Jun; 26(6):513-8. PubMed ID: 15891594 [TBL] [Abstract][Full Text] [Related]